Assessing the impact of early detection biases on breast cancer survival of Catalan women

Survival estimates for women with screen-detected breast cancer are affected by biases specific to early detection. Lead-time bias occurs due to the advance of diagnosis, and length-sampling bias because tumors detected on screening exams are more likely to have slower growth than tumors symptomatic...

Descripción completa

Detalles Bibliográficos
Autores: Roso-Llorach, Albert, Forné, Carles, Macià, Francesc, Galceran, Jaume, Marcos-Gragera, Rafael, Rué, Montserrat
Tipo de recurso: artículo
Fecha de publicación:2014
País:España
Institución:Universitat Politècnica de Catalunya (UPC)
Repositorio:UPCommons. Portal del coneixement obert de la UPC
Idioma:inglés
OAI Identifier:oai:upcommons.upc.edu:2117/88561
Acceso en línea:https://hdl.handle.net/2117/88561
Access Level:acceso abierto
Palabra clave:Breast cancer
early detection
screening
lead time bias
length bias
survival
Classificació AMS::62 Statistics::62N Survival analysis and censored data
Classificació AMS::62 Statistics::62P Applications
Àrees temàtiques de la UPC::Matemàtiques i estadística::Estadística matemàtica
Descripción
Sumario:Survival estimates for women with screen-detected breast cancer are affected by biases specific to early detection. Lead-time bias occurs due to the advance of diagnosis, and length-sampling bias because tumors detected on screening exams are more likely to have slower growth than tumors symptomatically detected. Methods proposed in the literature and simulation were used to assess the impact of these biases. If lead-time and length-sampling biases were not taken into account, the median survival time of screen-detected breast cancer cases may be overestimated by 5 years and the 5-year cumulative survival probability by between 2.5 to 5 percent units.